Marketing empowerment : how corporations co-opt feminist narratives to promote non-evidence based health interventions
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:384 |
|---|---|
| Enthalten in: |
BMJ (Clinical research ed.) - 384(2024) vom: 14. Feb., Seite e076710 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Copp, Tessa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.02.2024 Date Revised 27.02.2024 published: Electronic CommentIn: BMJ. 2024 Feb 14;384:q314. - PMID 38355156 Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmj-2023-076710 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368452611 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368452611 | ||
| 003 | DE-627 | ||
| 005 | 20240229164420.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240215s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmj-2023-076710 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1309.xml |
| 035 | |a (DE-627)NLM368452611 | ||
| 035 | |a (NLM)38355160 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Copp, Tessa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Marketing empowerment |b how corporations co-opt feminist narratives to promote non-evidence based health interventions |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2024 | ||
| 500 | |a Date Revised 27.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a CommentIn: BMJ. 2024 Feb 14;384:q314. - PMID 38355156 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Pickles, Kristen |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Jenna |e verfasserin |4 aut | |
| 700 | 1 | |a Hersch, Jolyn |e verfasserin |4 aut | |
| 700 | 1 | |a Johansson, Minna |e verfasserin |4 aut | |
| 700 | 1 | |a Doust, Jenny |e verfasserin |4 aut | |
| 700 | 1 | |a McKinn, Shannon |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Sweekriti |e verfasserin |4 aut | |
| 700 | 1 | |a Hardiman, Leah |e verfasserin |4 aut | |
| 700 | 1 | |a Nickel, Brooke |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ (Clinical research ed.) |d 1988 |g 384(2024) vom: 14. Feb., Seite e076710 |w (DE-627)NLM012612685 |x 1756-1833 |7 nnns |
| 773 | 1 | 8 | |g volume:384 |g year:2024 |g day:14 |g month:02 |g pages:e076710 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmj-2023-076710 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 384 |j 2024 |b 14 |c 02 |h e076710 | ||